These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30145977)

  • 1. [Device therapy in heart failure].
    Kozhuharov N; Sticherling C; Schär B
    Ther Umsch; 2018 Sep; 75(3):187-192. PubMed ID: 30145977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
    Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Device therapy in chronic heart failure].
    Schaer BA; Sticherling C
    Ther Umsch; 2011 Feb; 68(2):89-93. PubMed ID: 21271539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac electronic implantable devices in the treatment of heart failure.
    Tan TC; Sindone AP; Denniss AR
    Heart Lung Circ; 2012 Jun; 21(6-7):338-51. PubMed ID: 22682103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure.
    Choi AJ; Thomas SS; Singh JP
    Heart Fail Clin; 2016 Jul; 12(3):423-36. PubMed ID: 27371518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defibrillators: Selecting the Right Device for the Right Patient.
    Al-Khatib SM; Friedman P; Ellenbogen KA
    Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter defibrillators and cardiac resynchronisation therapy.
    Holzmeister J; Leclercq C
    Lancet; 2011 Aug; 378(9792):722-30. PubMed ID: 21856486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All cause mortality of cardiac resynchronization therapy with implantable cardioverter defibrillator: a meta-analysis of randomized controlled trials.
    Huang Y; Wu W; Cao Y; Qu N
    Int J Cardiol; 2010 Dec; 145(3):413-7. PubMed ID: 20541819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes Mellitus and Outcomes of Cardiac Resynchronization With Implantable Cardioverter-Defibrillator Therapy in Older Patients With Heart Failure.
    Echouffo-Tcheugui JB; Masoudi FA; Bao H; Spatz ES; Fonarow GC
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27489243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current attitudes on cardiac devices in heart failure: a review.
    Marangou J; Paul V
    Clin Ther; 2015 Oct; 37(10):2206-14. PubMed ID: 26386500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et Gérontologie.
    Fauchier L; Alonso C; Anselme F; Blangy H; Bordachar P; Boveda S; Clementy N; Defaye P; Deharo JC; Friocourt P; Gras D; Halimi F; Klug D; Mansourati J; Obadia B; Pasquié JL; Pavin D; Sadoul N; Taieb J; Piot O; Hanon O
    Arch Cardiovasc Dis; 2016 Oct; 109(10):563-585. PubMed ID: 27595465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronisation therapy with an implantable cardioverter defibrillator appears to be cost-effective in patients with mild heart failure.
    Cooper K
    Evid Based Med; 2016 Jun; 21(3):88. PubMed ID: 26887422
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
    Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B
    Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience.
    Liberska A; Kowalski O; Mazurek M; Lenarczyk R; Jędrzejczyk-Patej E; Przybylska-Siedlecka K; Kozieł M; Morawski S; Podolecki T; Kowalczyk J; Pruszkowska P; Pluta S; Sokal A; Kalarus Z
    Kardiol Pol; 2016; 74(8):741-748. PubMed ID: 26898970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.
    Freeman JV; Masoudi FA
    Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.